ScholarIQanswers from OpenAlex
University of Malaya
InstitutionResearch output, impact & collaborations
University of Malaya is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of Malaya?
ScholarIQrecord summary
University of Malaya is a research organisation in Kuala Lumpur, MY. OpenAlex records 111,432 works and 5,996,245 citations for it. 25,955 researchers list it as their most recent affiliation.
How many works does University of Malaya have?
ScholarIQindexed works
University of Malaya has 111,432 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of Malaya have?
ScholarIQcitation count
University of Malaya has 5,996,245 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of Malaya?
ScholarIQresearcher count
University of Malaya has 25,955 researchers in the ScholarIQ index.
What is the average h-index at University of Malaya?
ScholarIQavg h-index
University of Malaya has an average h-index of 52.1 in OpenAlex.
What is the ROR of University of Malaya?
ScholarIQror
The ROR for University of Malaya is on the source record.
What is the OpenAlex record for University of Malaya?
ScholarIQopenalex
The OpenAlex for University of Malaya is on the source record.
Who are the most-cited researchers behind University of Malaya?
ScholarIQtop researchers by citations
What are the most-cited papers on University of Malaya?
ScholarIQmost cited works
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, Quentin M. Anstee, Giovanni Targher, Manuel Romero‐Gómez, Shira Zelber‐Sagi, Vincent Wai‐Sun Wong, Jean‐François Dufour, Jörn M. Schattenberg, Takumi Kawaguchi, Marco Arrese, Luca Valenti, Gamal Shiha, Claudio Tiribelli, Hannele Yki‐Järvinen, Jian-Gao Fan, Henning Grønbæk, Yusuf Yılmaz, Helena Cortez‐Pinto, Cláudia P. Oliveira, Pierre Bédossa, Leon A. Adams, Ming‐Hua Zheng, Yasser Fouad, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Sang Hoon Ahn, Laurent Castéra, Elisabetta Bugianesi, Vlad Ratziu, Jacob George
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony Mok, Yi‐Long Wu, Iveta Kudaba, Dariusz M. Kowalski, Byoung Chul Cho, H.Z. Turna, Gilberto de Castro, Vichien Srimuninnimit, К. К. Лактионов, Igor Bondarenko, Kaoru Kubota, Gregory M. Lubiniecki, Jin Zhang, Debra Kush, Gilberto Lopes, Grigory Adamchuk, Myung‐Ju Ahn, Aurelia Alexandru, Özden Altundağ, Anna Alyasova, Orest Andrusenko, Keisuke Aoe, António Araújo, Osvaldo Rudy Aren, Oscar Arrieta Rodriguez, Touch Ativitavas, Oscar Avendaño, Fernando Barata, Carlos H. Barrios, Carlos Beato, Per Bergström, Daniel Betticher, Л. В. Болотина, Igor Bondarenko, Michiel Botha, Sayeuri Buddu, Christian Caglevic, Andrés F. Cardona, Gilberto de Castro, Hugo R. Castro, Filiz Çay Şenler, Carlos Alexandre Sydow Cerny, Alvydas Česas, Gee-Chen Chan, Jianhua Chang, Gongyan Chen, Xi Chen, Susanna Cheng, Ying Cheng, Nelly Cherciu, Chao‐Hua Chiu, Byoung Chul Cho, Saulius Cicėnas, Daniel Ciurescu, Graham Cohen, Marcos André Costa, Pongwut Danchaivijitr, Flávia De Angelis, Sérgio Jobim Azevedo, Mircea Dediu, Tsvetan Deliverski, Pedro Rafael Martins De Marchi, Flor de The Bustamante Valles, Zhenyu Ding, Boyan Doganov, Lydia Dreosti, Ricardo Duarte, Regina Edusma-Dy, S. A. Emelyanov, Mustafa Erman, Yun Fan, Luis Fein, Jifeng Feng, David Fenton, Gustavo dos Santos Fernandes, Carlos Gil Ferreira, Fábio Franke, H. Freitas, Yasuhito Fujisaka, Héctor Galindo, Christina Galvez, Doina Ganea, Nuno Gil, Gustavo Girotto, Erdem Göker, Tuncay Göksel, Gonzalo Gomez Aubin, Luis Gomez Wolff, Håkan Griph, Mahmut Gümüş, Jacqueline A. Hall, Gregory Hart, Libor Havel, Jianxing He, Yong He, Carlos Hernández Hernández, Venceslau Hespanhol, Tomonori Hirashima, Chung Man James Ho, Atsushi Horiike
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming‐Hua Zheng, Gamal Shiha, Yusuf Yılmaz, Rino Alvani Gani, Shahinul Alam, Yock Young Dan, Jia‐Horng Kao, Saeed Hamid, Ian Homer, Wah‐Kheong Chan, Diana A. Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome, M. Sasso, Jonathan J Deeks, Angelo H. Paredes, Jérôme Boursier, Wah‐Kheong Chan, Yusuf Yılmaz, Sébastien Czernichow, Ming‐Hua Zheng, Vincent Wai‐Sun Wong, Michael Allison, Emmanuel Tsochatzis, Quentin M. Anstee, David Sheridan, Peter Eddowes, Indra Neil Guha, Jeremy Cobbold, Valérie Paradis, Pierre Bédossa, Véronique Miette, Céline Fournier‐Poizat, Laurent Sandrin, Stephen Harrison
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
Yi‐Long Wu, Caicun Zhou, Chong Kin Liam, Gang Wu, Xuan Liu, Zhaoyang Zhong, Shun Lü, Ying Cheng, Baohui Han, Lin Chen, Cheng Huang, Shanshan Qin, Yixiang Zhu, Hui Pan, Houjie Liang, Elizabeth Li, Guangliang Jiang, Soon Hin How, Mitchel Fernando, Y. Zhang, Fan Xia, Yanchen Zuo
How much of the research on University of Malaya is open access?
ScholarIQopen access share
83%OPEN ACCESS